Suppr超能文献

激肽释放酶 7 在肿瘤发生中的作用。

The Role of Kallikrein 7 in Tumorigenesis.

机构信息

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Medical College, China Three Gorges University, Yichang, 443003, P.R. China.

The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443003, P.R. China.

出版信息

Curr Med Chem. 2022;29(15):2617-2631. doi: 10.2174/0929867328666210915104537.

Abstract

Kallikrein 7 (KLK7) is a secreted serine protease with chymotrypsic protease activity. Abnormally high expression of KLK7 is closely related to the occurrence and development of various types of cancer. Therefore, KLK7 has been identified as a potential target for cancer drug development design in recent years. KLK7 mediates various biological and pathological processes in tumorigenesis, including cell proliferation, migration, invasion, angiogenesis, and cell metabolism, by hydrolyzing a series of substrates such as membrane proteins, extracellular matrix proteins, and cytokines. This review mainly introduces the downstream cell signaling pathways involved in the activation of KLK7 and its substrate-related proteins. This review will not only help us to better understand the mechanisms of KLK7 in regulating biological and pathological processes of cancer cells but also lay a solid foundation for the design of inhibitors targeting KLK7.

摘要

激肽释放酶 7(KLK7)是一种具有糜蛋白酶活性的分泌型丝氨酸蛋白酶。KLK7 的异常高表达与各种类型癌症的发生和发展密切相关。因此,近年来 KLK7 已被确定为癌症药物开发设计的潜在靶点。KLK7 通过水解膜蛋白、细胞外基质蛋白和细胞因子等一系列底物,介导肿瘤发生过程中的多种生物学和病理学过程,包括细胞增殖、迁移、侵袭、血管生成和细胞代谢。本综述主要介绍了 KLK7 激活及其底物相关蛋白涉及的下游细胞信号通路。本综述不仅有助于我们更好地理解 KLK7 调节癌细胞生物学和病理学过程的机制,也为靶向 KLK7 的抑制剂设计奠定了坚实的基础。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验